CHRISTINE LESLIE: Open Payments
NPI 1912417205 · BRENTWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,958 in 64 payments from 35 companies in 2025. Trend: 2023 $3,432 · 2024 $4,293 · 2025 $1,958
Food & beverage: $1,409Long term medical supply or device loan: $399Education: $150
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $530 |
| Janssen Biotech, Inc. | 4 | $171 |
| Gilead Sciences, Inc. | 2 | $116 |
| Celgene Corporation | 3 | $79 |
| Boston Scientific Corporation | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Alexion Pharmaceuticals, Inc. | 3 | $58 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Astellas Pharma US Inc | 2 | $51 |
Products named: KISQALI, RYBREVANT, Trodelvy, REBLOZYL, WaveWriter Alpha Prime 16, ULTOMIRIS, ENHERTU, ZEPZELCA.
Industry payments across TN — which companies pay providers there.
